Crizanlizumab to prevent crises in sickle cell disease.
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 34, doi. 10.1002/psb.2012
- Publication type:
- Article
Works matching IS 09596682 AND DT 2022 AND VI 33 AND IP 8
Results: 8
1
2
Abrocitinib for the treatment of atopic dermatitis.
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 31, doi. 10.1002/psb.2011
- Publication type:
- Article
3
Updated guideline on diagnosing and managing epilepsies.
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 28, doi. 10.1002/psb.2010
- Publication type:
- Article
4
Highlights of the 2022 Clinical Pharmacy Congress.
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 24, doi. 10.1002/psb.2009
- Publication type:
- Article
5
Why have we neglected fungal infections?
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 20, doi. 10.1002/psb.2008
- Publication type:
- Article
6
Prescribing Skills Assessment.
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 19, doi. 10.1002/psb.2007
- Publication type:
- Article
7
A guide to prescribing antidepressants in primary care.
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 11, doi. 10.1002/psb.2006
- By:
- Publication type:
- Article
8
Getting under the skin of fungal infections.
- Published in:
- Prescriber, 2022, v. 33, n. 8, p. 4, doi. 10.1002/psb.2005
- Publication type:
- Article